Surveillance AFter Extremity Tumor surgerY
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Michelle Ghert, MD
McMaster University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario Austral
Buenos Aires, Argentina
- St. Vincent'S Hospital Melbourne
Fitzroy, Melbourne, Australia
- Lkh - Universitätsklinikum Graz
Graz, Austria
- Cliniques Universitaires Saint-Luc
Brussels, Belgium
- Hospital de Clínicas de Porto Alegre
Porto Alegre, Brazil
- Nova Scotia Health
Halifax, Nova Scotia, Canada
- Juravinski Hospital and Cancer Centre
Hamilton, Ontario, Canada
- the Ottawa Hospital
Ottawa, Ontario, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Mcgill University Health Centre
Montreal, Quebec, Canada
- Hôtel Dieu Du Quebec
Québec, Quebec, Canada
- Helios Klinikum Berlin
Berlin, Germany
- Centro Traumatologico Ortopedico Hospital
Turin, Italy
- University Malaya Kuala Lumpur
Kuala Lumpur, Malaysia
- Leiden University Medical Center
Leiden, Netherlands
- Centro Hospitalar E Universitario de Coimbra
Coimbra, Portugal
- Hospital Vall D'Hebron
Barcelona, Spain
- Karolinska University Hospital
Stockholm, Sweden
- University of California Davis Medical Center
Sacramento, California, United States
- Hartford Healthcare
Hartford, Connecticut, United States
- University of Florida Health Shands Hospital
Gainesville, Florida, United States
- Uchicago Medicine
Chicago, Illinois, United States
- Parkview Cancer Institute
Fort Wayne, Indiana, United States
- Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Albany Medical Center
Albany, New York, United States
- Nyu Langone Orthopaedic Hospital/perlmutter Cancer Center
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Oregon Health and Science University Hospital
Portland, Oregon, United States
- Allegheny Health Network Research Institute
Monroeville, Pennsylvania, United States
- Texas Tech Health Sciences Center
El Paso, Texas, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Nov 2019
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2027
- Last update posted
- 22 Nov 2024
- Registered enrollment
- 310
- Registry id
- NCT03944798
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.